EdgarLookup

Dyne Therapeutics, Inc.

DYN NASDAQ CIK: 0001818794 Pharmaceutical Preparations Inc. in DE
View on SEC.gov →
Overview All Filings Annual Quarterly Insiders

Recent Filings

All 643 filings →
Form Description Date
S-8 S-8 Mar 27, 2026
SCHEDULE 13G/A — Mar 26, 2026
4 4 Mar 13, 2026
4 4 Mar 13, 2026
4 4 Mar 11, 2026
144 — Mar 11, 2026
4 4 Mar 10, 2026
144 — Mar 9, 2026
4 4 Mar 6, 2026
4 4 Mar 6, 2026

Insider Transactions

View all →
Insider Title Type Shares Owns After Date
Cox John CEO & President Sale 2,662 @ $20.72 196,877 Dec 5, 2025
Kerr Douglas Chief Medical Officer Sale 880 @ $20.72 87,510 Dec 5, 2025
Friedl-Naderer Johanna Chief Commercial Officer Sale 144 @ $20.72 94,729 Dec 5, 2025
Cox John CEO & President Sale 2,640 @ $13.41 199,539 Sep 5, 2025
Friedl-Naderer Johanna Chief Commercial Officer Sale 144 @ $13.41 94,873 Sep 4, 2025
Kerr Douglas Chief Medical Officer Sale 873 @ $13.41 88,390 Sep 4, 2025
Cox John CEO & President Sale 4,060 @ $13.35 142,179 Jun 5, 2025
Kerr Douglas Chief Medical Officer Sale 1,342 @ $13.35 92,815 Jun 5, 2025
Friedl-Naderer Johanna Chief Commercial Officer Sale 146 @ $13.35 95,911 Jun 5, 2025
Lucera Erick Chief Financial Officer Award / Grant 66,100 66,100 Mar 31, 2025